WILMINGTON, Del.--(BUSINESS WIRE)--Positive high-level results from a pre-specified interim analysis of the Phase III TULIP-SC trial in patients with systemic lupus erythematosus (SLE) showed that the ...
On-body delivery systems for subcutaneous isatuximab could enable patient self-administration, according to Xavier Leleu, MD, PhD, improving convenience and transforming treatment for ...
The State Department outlined a new plan Thursday to move from global health aid to fostering the self-reliance of countries the U.S. has supported in prior years. The U.S. will focus on working ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results